Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant ... We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant blood disorders as well as the facilitation of safer and more accessible organ transplantations. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -9.67741935484 | 0.31 | 0.3359 | 0.2442 | 19604 | 0.29167975 | CS |
| 4 | -0.0199 | -6.63554518173 | 0.2999 | 0.37 | 0.24 | 13173 | 0.28711823 | CS |
| 12 | -0.003 | -1.06007067138 | 0.283 | 0.625 | 0.24 | 19296 | 0.3612907 | CS |
| 26 | 0.00513 | 1.86633681377 | 0.27487 | 0.8401 | 0.139 | 21248 | 0.39879579 | CS |
| 52 | -0.12 | -30 | 0.4 | 0.8401 | 0.0002 | 18206 | 0.38937742 | CS |
| 156 | -0.47 | -62.6666666667 | 0.75 | 1.5 | 0.0002 | 14789 | 0.42225026 | CS |
| 260 | -0.23 | -45.0980392157 | 0.51 | 2.55 | 0.0002 | 10511 | 0.70505975 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
